Corporate
  • bioMérieux

    Created in 1963
  • Social networks

    1,684 306,213
  • Sectors

  • Location

    100 All. Louis Raymond, 69280 Marcy-l'Étoile, France

    Marcy-l'Étoile

    France

  • Engaged entities

    239
    178 45
  • Added in Motherbase

    18 Sep 2019, 4:49 p.m.
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
Investinor Investinor
Venture Capital and Private Equity Principals
Other

29 Feb 2024


Eurobio Scientific Eurobio Scientific
biotech, deeptech, Biotechnology Research
Other

3 Apr 2024


EPPUR EPPUR
manufacturing, healthtech, Hospitals and Health Care
Other

5 Apr 2024


Fédération des Aveugles et Amblyopes de France Fédération des Aveugles et Amblyopes de France
healthtech, Civic and Social Organizations
Other

6 Apr 2024


LittleBig Connection LittleBig Connection
IT Services, Software Development
Other

29 Feb 2024


Sounds Commercial Sounds Commercial
entertainment, Events Services
Other

15 Mar 2024


1CABASPOUR1ETUDIANT 1CABASPOUR1ETUDIANT
IT Services, Non-profit Organizations
Other

22 Mar 2024


Tricog Health Tricog Health
healthtech, Hospitals and Health Care
Other

25 Mar 2024


Milleis Banque Milleis Banque
fintech, Financial Services
Other

20 Mar 2024


Abingdon Health plc Abingdon Health plc
biotech, manufacturing, deeptech, healthtech, Medical Equipment Manufacturing
Other

18 Mar 2024


Radars
Loading...